I

I Sens Inc
KOSDAQ:099190

Watchlist Manager
I Sens Inc
KOSDAQ:099190
Watchlist
Price: 18 730 KRW -2.24% Market Closed
Market Cap: 517.6B KRW
Have any thoughts about
I Sens Inc?
Write Note

I Sens Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

I Sens Inc
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
I
I Sens Inc
KOSDAQ:099190
Additional Paid In Capital
â‚©41.7B
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
-1%
Dentium Co Ltd
KRX:145720
Additional Paid In Capital
â‚©49.3B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
B
Biodyne Co Ltd
KOSDAQ:314930
Additional Paid In Capital
â‚©66.3B
CAGR 3-Years
69%
CAGR 5-Years
88%
CAGR 10-Years
N/A
J
Jeisys Medical Inc
KOSDAQ:287410
Additional Paid In Capital
â‚©27.2B
CAGR 3-Years
1%
CAGR 5-Years
30%
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Additional Paid In Capital
â‚©24.2B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
N/A
L
Lutronic Corp
KOSDAQ:085370
Additional Paid In Capital
â‚©83B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
16%
No Stocks Found

I Sens Inc
Glance View

Market Cap
515.2B KRW
Industry
Health Care

i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-01-30. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The firm distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.

Intrinsic Value
21 099.3 KRW
Undervaluation 11%
Intrinsic Value
Price
I

See Also

What is I Sens Inc's Additional Paid In Capital?
Additional Paid In Capital
41.7B KRW

Based on the financial report for Jun 30, 2024, I Sens Inc's Additional Paid In Capital amounts to 41.7B KRW.

What is I Sens Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
-1%

Over the last year, the Additional Paid In Capital growth was 3%. The average annual Additional Paid In Capital growth rates for I Sens Inc have been -3% over the past three years , -2% over the past five years , and -1% over the past ten years .

Back to Top